Peter Atadja
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Molecular Biology top 0.5%
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
- Cancer-related gene regulation
Papers in
-
- Histone Deacetylase Inhibitors Research 105
- Protein Degradation and Inhibitors 36
- Epigenetics and DNA Methylation 33
- Ubiquitin and proteasome pathways 19
- Cancer-related gene regulation 15
- Signaling Pathways in Disease 11
- Hematology 33
- Acute Myeloid Leukemia Research 17
- Co-authors
- Kapil N. Bhalla (43 shared papers)Warren Fiskus (33 shared papers)Purva Bali (14 shared papers)Ricky W. Johnstone (10 shared papers)Leigh Ellis (6 shared papers)Lin Gao (2 shared papers)Maria A. Cueto (1 shared paper)Karl Riabowol (9 shared papers)
- Journals
- Blood (33 papers)Journal of Clinical Oncology (14 papers)Cancer Research (14 papers)Clinical Cancer Research (12 papers)Molecular Cancer Therapeutics (10 papers)
- Partner nations
- United StatesSwitzerlandChina
In The Last Decade
Peter Atadja
148 papers receiving 11.0k citations
Peter Atadja's Hit Papers
Peers
Comparison fields: 5 of 128
- Hematology 1.6k
- Molecular Biology 9.1k
- Oncology 2.3k
- Cancer Research 795
- Geriatrics and Gerontology 170
Countries citing papers authored by Peter Atadja
This map shows the geographic impact of Peter Atadja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Atadja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Atadja more than expected).
Fields of papers citing papers by Peter Atadja
This network shows the impact of papers produced by Peter Atadja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Atadja. The network helps show where Peter Atadja may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Atadja, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90 Hit paper breakdown → | 2005 | 646 |
| 2 | Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family Hit paper breakdown → | 2002 | 560 |
| 3 | 2009 | 366 | |
| 4 | 2008 | 356 | |
| 5 | 2009 | 339 | |
| 6 | 2009 | 292 | |
| 7 | 2004 | 273 | |
| 8 | 2006 | 270 | |
| 9 | 2006 | 267 | |
| 10 | 1995 | 255 | |
| 11 | 2008 | 247 | |
| 12 | 2014 | 238 | |
| 13 | Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells. | 2003 | 237 |
| 14 | 2006 | 235 | |
| 15 | Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B. | 2003 | 228 |
| 16 | 2006 | 194 | |
| 17 | 2004 | 190 | |
| 18 | 2003 | 188 | |
| 19 | 2008 | 187 | |
| 20 | 2013 | 170 |
About Peter Atadja
Peter Atadja is a scholar working on Molecular Biology, Hematology, Oncology, Immunology and Physiology, having authored 150 papers that have together received 11.3k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (105 papers), Protein Degradation and Inhibitors (36 papers), Epigenetics and DNA Methylation (33 papers), Ubiquitin and proteasome pathways (19 papers), Acute Myeloid Leukemia Research (17 papers), Cancer-related gene regulation (15 papers), Peptidase Inhibition and Analysis (12 papers) and Signaling Pathways in Disease (11 papers). The work is most often cited by research in Hematology (1.6k citations), Molecular Biology (9.1k citations), Oncology (2.3k citations), Cancer Research (795 citations) and Geriatrics and Gerontology (170 citations). Peter Atadja has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Kapil N. Bhalla, Warren Fiskus, Purva Bali, Ricky W. Johnstone, Leigh Ellis, Lin Gao, Maria A. Cueto, Karl Riabowol, Fei Guo and Роберто Пили. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.